Drug companies poured lots of resources into seeking a vaccine for staph infections, but have yet to succeed.

In Maryland, a startup is joining the effort.

Serenta Biotechnology, which is based in Gaithersburg, is working to build on technology that was effective in animal trials.

READ FULL ARTICLE HERE